Research engineers from the Massachusetts Institute of Technology have found a way to prevent scar tissue from disabling implantable devices. If established as safe and effective in humans, this technology could prove transformative in treating many diseases, such as diabetes.
Posts
Thursday morning, Takeda reported its quarterly sales ending June 30, 2022. The company reported a 2.4% increase in revenue for the quarter from the same period in 2021, as well as changes to its pipeline, including a decision to drop a cancer therapeutic developed with Turnstone Biologics.
French drugmaker Sanofi said on Wednesday uninsured diabetes patients in the United States will pay no more than $35 for a 30-day supply of insulin, in the wake of heightened public scrutiny over soaring prices of the life-saving drug.
Danish researchers published a study suggesting that COVID-19 increases the risk of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
Among the winners, VMLY&R Takes Pharma Grand Prix, Area 23 Wins Healthcare Agency of the Year
Diabetes may increase the risk of long COVID, new analyses of seven previous studies suggest. Researchers have also found that babies born to mothers who had COVID-19 while pregnant may be at higher than average risk for problems with brain development involved in learning, focusing, remembering, and developing social skills.
Ginkgo Bioworks, a leading horizontal platform for cell programming, announced a collaboration with Novo Nordisk, a leading global healthcare company, to create novel expression hosts for pharmaceutical products.
This industry breakthrough introduces a critical component for the potential treatment of T1D in the setting of an autologous cell transplantation. Type 1 diabetes affects approximately 1.6 million people in the US and more than 20 million people worldwide.
Eli Lilly is expanding the Indianapolis-based company’s footprint in Indiana through a $2.1 billion investment.
Klick Health hired 37-time Cannes Lions and 80-time Clio awards recipient Bernardo Romero to become the agency’s ‘Maker’ – a role that was specially created around his desire to return to creating campaigns and products that positively impact people’s health. Romero, who was Chief Creative Officer at The Bloc, wants to bring his patient experience as someone who has diabetes into his work. Romero and Klick Health Chief Creative Officer Rich Levy talked to Med Ad News about what brought Romero to Klick and the launch of The Workshop, a Klick team of “Makers, Concepters, Noodlers and Doodlers” that will be experimenting with new ideas for creative healthcare advertising.